Skip to main content
Published locations for CPX-351 vs standard chemotherapy continues to show improved OS in high-risk or secondary AML
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
CPX-351 vs standard chemotherapy continues to show improved OS in high-risk or secondary AML
User login
Username
Password
Reset your password
/content/cpx-351-vs-standard-chemotherapy-continues-show-improved-os-high-risk-or-secondary-aml
/hematology-oncology/article/243640/aml/cpx-351-vs-standard-chemotherapy-continues-show-improved-os